Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: LTI, SolveBio, Proteon, & More 05/16/14 Boston
Gelesis Resurfaces With $12M, Preps First Weight Loss Data 05/16/14 Boston
San Diego Life Sciences Roundup: Deals at MEI Pharma, Auspex, Ambit 11/09/12 San Diego
LoseIt, With 10M+ Users, Looks to Turn Weight Loss App Into Big Business 03/13/12 Boston
Arena Passes Small Study, in Bid to Answer FDA Questions About Obesity Drug 08/02/11 San Diego
Zafgen Pockets $33M To Take Obesity Drug Through Next Big Step in Clinical Trials 07/07/11 Boston
Vivus to Try Again By Year’s End 02/28/11 San Francisco
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug 01/27/11 San Diego
Arena Reloads for Round 2 with FDA, With More Data on Weight Loss Drug in Diabetes Patients 11/09/10 San Diego
Gelesis, With Obesity Drug That Swells Up in Stomach, Helps Rats Eat Less 10/11/10 Boston
Orexigen Nabs $1B Deal With Takeda to Market Obesity Drug, Shares Climb 09/02/10 San Diego
Vivus Obesity Drug Shot Down by FDA Panel, in Close Vote 07/15/10 San Francisco
Vivus Faces Turning Point in Obesity Drug Battle Tomorrow With Arena, Orexigen 07/14/10 San Francisco
Arena Adds $35M From Deerfield 06/03/10 San Diego
Zafgen’s Mysterious Weight Loss Drug Advances Into First Trial for Obese Women 02/08/10 Boston
Arena Loses Merck Collaboration After Clogged-Artery Drug Fails Clinical Trial 12/23/09 San Diego
Orexigen Obesity Drug Hits Weight Loss Goal in Studies, Company Looks Toward FDA 07/20/09 San Diego
Page 1 of 1